XML 85 R75.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS - Narrative (Details)
 3 Months Ended 12 Months Ended
Apr. 06, 2023
shares
Apr. 07, 2022
USD ($)
shares
Feb. 28, 2022
USD ($)
$ / shares
shares
Dec. 30, 2021
USD ($)
shares
Jul. 23, 2021
USD ($)
$ / shares
shares
Jun. 24, 2021
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 16, 2022
USD ($)
Mar. 26, 2022
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Derivative liability, converted amount             $ 6,650,000 $ 156,000      
Balance of investments measured at fair value             $ 0   $ 24,000    
Common stock, shares outstanding (in shares) | shares             103,035,152   91,442,018    
Equity securities, FV-NI, gain (loss)             $ 0 407,393      
Change in fair value Tonogold note receivable             $ 0 605,000      
Closing stock price (in usd per share) | $ / shares     $ 1.46       $ 0.34   $ 0.28    
Change in fair value of derivative instruments             $ 698,595 $ 3,065,000      
Subsequent Event                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Common stock, shares outstanding (in shares) | shares 102,707,603                    
Shares returned | shares 327,549                    
Ionic Ventures Unsecured Convertible Promissory Note                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Threshold percentage of stock price trigger             90.00%   90.00%    
Ionic Ventures Unsecured Convertible Promissory Note | Measurement Input, Cap Rate                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Equity securities, measurement input (as percent) | $ / shares             0.50   0.50    
Ionic Ventures Unsecured Convertible Promissory Note | Discount rate                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Measurement input, percent               35.00% 35.00%    
Ionic Ventures Unsecured Convertible Promissory Note | Risk fee rate                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Measurement input, percent               4.56% 4.40%    
Ionic Ventures Unsecured Convertible Promissory Note | Volatility rate                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Measurement input, percent               85.00% 60.00%    
Ionic Ventures Unsecured Convertible Promissory Note | Subsequent Event | Secured Debt                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Shares returned | shares 327,549                    
Quantum Generative Materials LLC                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Stock committed as investment in affiliates, subsidiaries and joint ventures             $ 1,200,000   $ 2,450,000    
LP Biosciences LLC                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Stock committed as investment in affiliates, subsidiaries and joint ventures         $ 4,173,000            
LP Biosciences LLC | Restricted Stock | Variable Interest Entity, Not Primary Beneficiary                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Shares issued in connection with investment and financing commitments (in shares) | shares     3,500,000   3,500,000            
LP Biosciences LLC | Fair Value, Measurements, Recurring                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Derivative asset     $ 5,110,000   $ 6,642,000            
Chief Executive Officer and Officers                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Number of shares issued in transaction (in shares) | shares       3,500,000              
Receivable on sale of equity securities       $ 7,258,162              
Tonogold Resources, Inc.                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Common stock, shares outstanding (in shares) | shares                 606,061    
Tonogold Resources, Inc. | Common Stock                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Common stock, shares outstanding (in shares) | shares             606,061        
Equity securities, FV-NI, gain (loss)                 $ 30,303    
Gain (loss) on change in fair value             $ 0 $ 415,205      
Tonogold                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Ownership percentage               100.00%      
Notes receivable current, before fair value adjustments               $ 6,650,000     $ 6,650,000
Ionic convertible debenture derivative                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Change in fair value of derivative instruments             210,000 1,330,000      
Ionic convertible debenture derivative | Fair Value, Measurements, Recurring                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Ionic convertible debenture derivative             5,468,162   6,053,162    
Ionic convertible debenture derivative | Chief Executive Officer and Officers | Ionic convertible debenture derivative                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Stock committed as investment in affiliates, subsidiaries and joint ventures             375,000   225,000    
Ionic convertible debenture derivative | Common Stock                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Common stock, number of shares purchased (in shares) | shares       3,129,081              
Quantum Generative Materials LLC                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Closing stock price (in usd per share) | $ / shares           $ 3.51          
Change in fair value of derivative instruments             158,595 1,140,000      
Quantum Generative Materials LLC | Fair Value, Measurements, Recurring                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Derivative asset           $ 530,000          
Quantum Generative Materials LLC | Quantum Generative Materials LLC | Affiliated Entity                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Stock committed as investment in affiliates, subsidiaries and joint ventures           $ 10,000,000          
Quantum Generative Materials LLC | Quantum Generative Materials LLC | Restricted Stock | Affiliated Entity                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Issuance of common stock (in shares) | shares           3,000,000          
Haywood derivative                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Gain (loss) on change in fair value             90,000   0    
Derivative asset   $ 245,000                  
Haywood derivative | Fair Value, Measurements, Recurring                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Ionic convertible debenture derivative             1,190,000   1,480,000    
Haywood derivative | Haywood derivative | Affiliated Entity                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Stock committed as investment in affiliates, subsidiaries and joint ventures   $ 2,100,000         200,000   150,000    
Issuance of common stock (in shares) | shares   1,500,000                  
Deposits   $ 50,000                  
LP Biosciences LLC                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Closing stock price (in usd per share) | $ / shares         $ 3.09            
Derivative asset     937,000                
Written off to other expense     $ 937,000                
LP Biosciences LLC | Mana Corporation                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Change in fair value of derivative instruments             595,000        
Ionic Ventures, LLC                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Increase (decrease) in derivative liabilities             240,000 $ 0      
Ionic convertible debenture derivative             $ 24,000   $ 420,000 $ 420,000